My hope is it is a false breakdown below $1, only to be snapped right back up if it breaks below 0.95. I will probably not buy until support at 0.80 (200DMA)... I still have faith in the company's drug candidates, but they have really dragged this along, so the faith in management is just not there, otherwise I'd be accumulating shares on any and every dip.
imuffin4: CYTK has NOT dragged this along! Don't you understand that Amgen runs the Mecarbil trials? They run diligent trials and do not proceed to the next phase until their science panel has vetted and approved continuation. Amgen looks at the long term(10 years). CYTK has stayed the course and so has Amgen.